Trial intelligence / Profile preview

AMDC in advanced ischemic heart failure

NCT01353690Phase 2Terminated

Sponsor
Cook MyoSite
Start
Feb 2011
Primary completion
Dec 2012
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of AMDC-USR in Ischemic Heart Failure (IHF), sponsored by Cook MyoSite. Started Feb 2011; status: terminated.

02

Drugs

AMDC-USR
03

Conditions

Ischemic Heart Failure (IHF)

Beyond the preview

Go deeper on NCT01353690.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01353690.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call